US Patent Issued to TAIWAN LIPOSOME, TLC BIOPHARMACEUTICALS on April 15 for "Sustained-release pharmaceutical compositions comprising an immunomodulating agent and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,785, issued on April 15, was assigned to TAIWAN LIPOSOME Co. LTD. (Taipei, Taiwan) and TLC BIOPHARMACEUTICALS INC. (South San Francisco, Calif.).

"Sustained-release pharmaceutical compositions comprising an immunomodulating agent and uses thereof" was invented by Keelung Hong (South San Francisco, Calif.), Walter Gwathney (South San Francisco, Calif.), Jonathan Fang (South San Francisco, Calif.), Hao-Wen Kao (South San Francisco, Calif.) and Yi-Yu Lin (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising at least one liposome and a therapeutic agent for tre...